Jalon(SH:688357) Shenwan Hongyuan Securities·2025-11-17 07:58Investment Rating - The investment rating for the company is maintained as "Outperform" [5]. Core Insights - The company reported a total revenue of 590 million yuan for the first three quarters of 2025, reflecting a year-over-year growth of 4%. The net profit attributable to the parent company was 73 million yuan, up 20% year-over-year [5]. - The second phase of the Thailand Jianlong project is gradually ramping up production, enhancing the company's overseas capacity coordination. The overseas sales revenue reached 155 million yuan, accounting for 26.21% of total revenue, with significant growth in the Thailand operations [5]. - The company is focusing on its core molecular sieve business and increasing R&D investments to expand application scenarios, aiming to improve market share and profitability [5]. Financial Data and Profit Forecast - The company forecasts total revenue of 819 million yuan for 2025, with a year-over-year growth rate of 5.2%. The net profit attributable to the parent company is projected to be 98 million yuan, representing a 31.3% increase [4]. - The gross profit margin is expected to be 29.5% in 2025, with a return on equity (ROE) of 5.5% [4]. - The average price of formed molecular sieve products is revised down from 26,700 yuan/ton to 17,500 yuan/ton for 2025, leading to a downward adjustment of the net profit forecast for 2025 to 98 million yuan [5].